Peer Review reports
From: Emerging avenues in immunotherapy for the management of malignant pleural mesothelioma
| Original Submission | ||
|---|---|---|
| 27 Nov 2020 | Submitted | Original manuscript |
| 2 Jan 2021 | Reviewed | Reviewer Report |
| 10 Jan 2021 | Reviewed | Reviewer Report - Steven Kao |
| 29 Jan 2021 | Author responded | Author comments - Steven G. Gray |
| Resubmission - Version 2 | ||
| 29 Jan 2021 | Submitted | Manuscript version 2 |
| 4 Mar 2021 | Reviewed | Reviewer Report |
| 6 Mar 2021 | Reviewed | Reviewer Report - Steven Kao |
| 18 Mar 2021 | Author responded | Author comments - Steven G. Gray |
| Resubmission - Version 3 | ||
| 18 Mar 2021 | Submitted | Manuscript version 3 |
| 20 Mar 2021 | Reviewed | Reviewer Report - Steven Kao |
| 18 Apr 2021 | Reviewed | Reviewer Report |
| 22 Apr 2021 | Author responded | Author comments - Steven G. Gray |
| Resubmission - Version 4 | ||
| 22 Apr 2021 | Submitted | Manuscript version 4 |
| Publishing | ||
| 25 Apr 2021 | Editorially accepted | |
| 5 May 2021 | Article published | 10.1186/s12890-021-01513-7 |
You can find further information about peer review here.